These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25606696)
1. Endogenous carbon monoxide and cardiometabolic risk: can measuring exhaled carbon monoxide be used to refine cardiometabolic risk assessment? Nayor M; Vasan RS Future Cardiol; 2015; 11(1):9-12. PubMed ID: 25606696 [No Abstract] [Full Text] [Related]
2. Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community. Cheng S; Lyass A; Massaro JM; O'Connor GT; Keaney JF; Vasan RS Circulation; 2010 Oct; 122(15):1470-7. PubMed ID: 20876437 [TBL] [Abstract][Full Text] [Related]
3. Special issue on carbon monoxide and exhaled biomarkers in human disease. Ryter SW J Breath Res; 2010 Dec; 4(4):040201. PubMed ID: 21383483 [No Abstract] [Full Text] [Related]
4. Monitoring of exhaled carbon monoxide and carbon dioxide during lung cancer operation. Khasag N; Sakiyama S; Toba H; Yoshida M; Nakagawa Y; Takizawa H; Kawakami Y; Kenzaki K; Ali AH; Kondo K; Tangoku A Eur J Cardiothorac Surg; 2014 Mar; 45(3):531-6. PubMed ID: 23913245 [TBL] [Abstract][Full Text] [Related]
5. Assessment of biochemical liver markers, physical activity, fitness and body mass index for a cardiometabolic risk model in childhood. Konidari A; Auth MK; Murphy MH; Cunningham C; Foweather L; Gobbi R; Graves LE; Hopkins ND; Stratton G; Boddy LM Acta Paediatr; 2014 May; 103(5):e194-8. PubMed ID: 24512112 [TBL] [Abstract][Full Text] [Related]
6. Gender-based cardiometabolic risk evaluation in minority and non-minority men grading the evidence of non-traditional determinants of cardiovascular risk. Billups KL; Miner MM; Wierzbicki AS; Jackson G Int J Clin Pract; 2011 Feb; 65(2):134-47. PubMed ID: 21199197 [TBL] [Abstract][Full Text] [Related]
7. Glycemic status, metabolic syndrome, and cardiovascular risk in children. Berenson GS; Agirbasli M; Nguyen QM; Chen W; Srinivasan SR Med Clin North Am; 2011 Mar; 95(2):409-17, ix. PubMed ID: 21281842 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus. Hayden MR; Sowers JR J Cardiometab Syndr; 2008; 3(3):129-31. PubMed ID: 18983326 [No Abstract] [Full Text] [Related]
9. Phosgene- and chlorine-induced acute lung injury in rats: comparison of cardiopulmonary function and biomarkers in exhaled breath. Luo S; Trübel H; Wang C; Pauluhn J Toxicology; 2014 Dec; 326():109-18. PubMed ID: 25456270 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acids and the cardiometabolic syndrome. Juturu V J Cardiometab Syndr; 2008; 3(4):244-53. PubMed ID: 19040594 [TBL] [Abstract][Full Text] [Related]
11. Emerging role of estrogen in the control of cardiometabolic disease. Cignarella A; Kratz M; Bolego C Trends Pharmacol Sci; 2010 Apr; 31(4):183-9. PubMed ID: 20138672 [TBL] [Abstract][Full Text] [Related]
12. Assessing risk across the spectrum of patients with the metabolic syndrome. Rosenson RS Am J Cardiol; 2005 Aug; 96(4A):8E-10E. PubMed ID: 16098836 [TBL] [Abstract][Full Text] [Related]
13. The importance of treating cardiometabolic risk factors in patients with type 2 diabetes. Barnett AH Diab Vasc Dis Res; 2008 Mar; 5(1):9-14. PubMed ID: 18398806 [TBL] [Abstract][Full Text] [Related]
14. Bronchoprovocation testing in asthma: effect on exhaled monoxides. Sethi JM; White AM; Patel SA; Dinella JV; Calhoun WJ; Choi AM J Breath Res; 2010 Dec; 4(4):047104. PubMed ID: 21383491 [TBL] [Abstract][Full Text] [Related]
15. Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. Smith JD; Borel AL; Nazare JA; Haffner SM; Balkau B; Ross R; Massien C; Alméras N; Després JP J Clin Endocrinol Metab; 2012 May; 97(5):1517-25. PubMed ID: 22337910 [TBL] [Abstract][Full Text] [Related]